Hongda Zhao

666 Changhui Road
Zhenjiang, 212100, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

EZH2 Inhibition Remodels Cell States and Enhances EGFRi Sensitization in Bladder Cancer.

EZH2 Inhibition Remodels Cell States and Enhances EGFRi Sensitization in Bladder Cancer.

Journal: European urology oncology

Published: April 13, 2026

Oncological Outcomes of Different Managements of the Distal Ureter in Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

Oncological Outcomes of Different Managements of the Distal Ureter in Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

Journal: European urology oncology

Published: November 27, 2025

Impact of H1 Antihistamines on Bacillus Calmette-Guérin-treated Non-muscle-invasive Bladder Cancer.

Impact of H1 Antihistamines on Bacillus Calmette-Guérin-treated Non-muscle-invasive Bladder Cancer.

Journal: European urology open science

Published: November 05, 2025

Radical Nephroureterectomy Pentafecta as a Predictor of Upper Tract Urothelial Carcinoma Outcomes Following Radical Surgery.

Radical Nephroureterectomy Pentafecta as a Predictor of Upper Tract Urothelial Carcinoma Outcomes Following Radical Surgery.

Journal: Annals of surgical oncology

Published: April 09, 2025

Impact of Antiaggregant and Anticoagulant Medications on Perioperative Complications in Upper Tract Urothelial Carcinoma.

Impact of Antiaggregant and Anticoagulant Medications on Perioperative Complications in Upper Tract Urothelial Carcinoma.

Journal: European urology open science

Published: February 16, 2025

A cross-sectional study on the effects of intravesical BCG on urinary microbiota in bladder cancer patients.

A cross-sectional study on the effects of intravesical BCG on urinary microbiota in bladder cancer patients.

Journal: International urology and nephrology

Published: February 10, 2025

Organoid models in bladder cancer: From bench to bedside?

Organoid models in bladder cancer: From bench to bedside?

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: November 26, 2024

Patient-Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment.

Patient-Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 08, 2024

The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancer.

The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancer.

Journal: BJU international

Published: September 11, 2024

Impact of smoking status at diagnosis on oncological outcomes of upper-tract urothelial carcinoma.

Impact of smoking status at diagnosis on oncological outcomes of upper-tract urothelial carcinoma.

Journal: Therapeutic advances in urology

Published: September 02, 2024

Association Between Hypoglycemia Agents and Long-term Survival Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guérin Immunotherapy.

Association Between Hypoglycemia Agents and Long-term Survival Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guérin Immunotherapy.

Journal: European urology oncology

Published: July 16, 2024

Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer.

Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer.

Journal: World journal of urology

Published: June 27, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026